Search
Enrolled in an accredited graduate degree program (e.g., PhD, PharmD, MD, MBA, MPH, MHA, MS, JD) in Summer 2025 with anticipated graduation by Summer 2026 or currently a Post-Doctoral Research Fellow.
Demonstrated interest in strategy consulting / business and the Life Sciences (e.g., pharmaceutical, biotech, MedTech companies)
Strong critical thinking, problem solving, creativity, and oral and written communication skills.
Available to attend the in-person Gateway to Guidehouse Life Sciences program in Chicago.
Learn: “Learning how to think like a Guidehouse consultant and how to communicate the 'so what' was one of the best professional skills I developed. I have been asking 'so what' during my case practices and while preparing my research presentations since then!" - Gateway to Guidehouse participant
Network: “I thoroughly enjoyed the Gateway to Guidehouse Life Sciences program. The opportunity to interact with the Guidehouse Life Sciences team across various seniority levels, as well as fellow participants throughout the program was incredibly rewarding. Everyone involved was exceptionally friendly and supportive, fostering a welcoming environment.” - Gateway to Guidehouse participant
Develop: “I really enjoyed the case simulation & presentation. It was really eye-opening and inspiring to learn from everyone's approach to the case. The feedback from the 'panel of clients' was crucial and helped me see both scientific and strategic perspectives.” - Gateway to Guidehouse participant
Application Timeline & Process Overview - Application portal is now open. Interested candidates must submit their application before 11:59PM ET on February 28, 2025. Candidates will receive invitations to interview for the program on a rolling basis and will proceed to one Behavioral and one Case Interview with Guidehouse LS team members. Candidates will be informed as to status of their candidacy no later than March 2025. Candidates are encouraged to apply early as participation offers will also be extended on a rolling basis.